{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:25:06Z","timestamp":1755217506051,"version":"3.43.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016211","name":"Zonguldak B\u00fclent Ecevit University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006002","name":"Zonguldak B\u00fclent Ecevit University","doi-asserted-by":"publisher","award":["2020\\u201393106430-01"],"award-info":[{"award-number":["2020\\u201393106430-01"]}],"id":[{"id":"10.13039\/501100006002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cca.2025.120275","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T22:28:51Z","timestamp":1743546531000},"page":"120275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["PARP-1 gene promoter region may be associated with progression in multiple sclerosis"],"prefix":"10.1016","volume":"572","author":[{"given":"Busra","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunes Cakmak","family":"Genc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevim Karakas","family":"Celik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilge Piri","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Acikgoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120275_b0005","unstructured":"Charcot, J. 1868.Comptes rendus des s\u00e9ances et m\u00e9moires lus \u00e0 la soci\u00e9t\u00e9 de Biologie."},{"issue":"9648","key":"10.1016\/j.cca.2025.120275_b0010","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.cca.2025.120275_b0015","unstructured":"https:\/\/www.msif.org\/wp-content\/uploads\/2020\/10\/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf."},{"issue":"9","key":"10.1016\/j.cca.2025.120275_b0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","author":"International Multiple Sclerosis Genetics Consortium","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cca.2025.120275_b0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/jnnp.57.4.491","article-title":"British Isles survey of multiple sclerosis in twins: MRI","volume":"57","author":"Thorpe","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.cca.2025.120275_b0030","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/brain\/aws012","article-title":"NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury","volume":"135","author":"Fischer","year":"2012","journal-title":"Brain J. Neurol."},{"issue":"3","key":"10.1016\/j.cca.2025.120275_b0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1474-4422(09)70043-2","article-title":"Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis","volume":"8","author":"Trapp","year":"2009","journal-title":"The Lancet. Neurology"},{"issue":"1","key":"10.1016\/j.cca.2025.120275_b0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2307\/3576299","article-title":"Poly(ADP-ribose) in the cellular response to DNA damage","volume":"101","author":"Berger","year":"1985","journal-title":"Radiat. Res."},{"issue":"7","key":"10.1016\/j.cca.2025.120275_b0045","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/00004647-200207000-00002","article-title":"Tricarboxylic acid cycle substrates prevent PARP-mediated death of neurons and astrocytes","volume":"22","author":"Ying","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"11","key":"10.1016\/j.cca.2025.120275_b0050","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1101\/gad.1199904","article-title":"Alkylating DNA damage stimulates a regulated form of necrotic cell death","volume":"18","author":"Zong","year":"2004","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.cca.2025.120275_b0055","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1523\/JNEUROSCI.5552-09.2010","article-title":"NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death","volume":"30","author":"Alano","year":"2010","journal-title":"J. Neurosci."},{"issue":"26","key":"10.1016\/j.cca.2025.120275_b0060","doi-asserted-by":"crossref","first-page":"17668","DOI":"10.1074\/jbc.M109.002931","article-title":"Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure","volume":"284","author":"Formentini","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.cca.2025.120275_b0065","doi-asserted-by":"crossref","first-page":"18895","DOI":"10.1074\/jbc.M313329200","article-title":"Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition","volume":"279","author":"Alano","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cca.2025.120275_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2353\/ajpath.2008.080019","article-title":"Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease","volume":"173","author":"Pacher","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.cca.2025.120275_b0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1212\/01.WNL.0000103291.04985.DC","article-title":"Widespread increased expression of the DNA repair enzyme PARP in brain in ALS","volume":"62","author":"Kim","year":"2004","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.cca.2025.120275_b0080","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/01.wnr.0000136175.51954.ce","article-title":"The expression of PARP, NF-kappa B and parvalbumin is increased in Parkinson disease","volume":"15","author":"So\u00f3s","year":"2004","journal-title":"Neuroreport"},{"issue":"10","key":"10.1016\/j.cca.2025.120275_b0085","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nn.3500","article-title":"Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss","volume":"16","author":"Lee","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.cca.2025.120275_b0090","doi-asserted-by":"crossref","first-page":"e919","DOI":"10.1038\/cddis.2013.447","article-title":"(ADP-ribose) polymerase 1 and AMP-activated protein kinase mediate progressive dopaminergic neuronal degeneration in a mouse model of Parkinson's disease","volume":"4","author":"Kim","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2025.120275_b0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuint.2014.07.001","article-title":"Targeting poly(ADP-ribose)polymerase1 in neurological diseases: A promising trove for new pharmacological interventions to enter clinical translation","volume":"76","author":"Sriram","year":"2014","journal-title":"Neurochem. Int."},{"issue":"9","key":"10.1016\/j.cca.2025.120275_b0100","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4103\/1673-5374.237109","article-title":"Role of nuclear factor \u03baB in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"13","author":"Yue","year":"2018","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.cca.2025.120275_b0105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1471-4159.2003.01684.x","article-title":"Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders","volume":"85","author":"Chiarugi","year":"2003","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.cca.2025.120275_b0110","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.052712399","article-title":"Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia","volume":"99","author":"Ha","year":"2002","journal-title":"PNAS"},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120275_b0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0165-5728(01)00329-0","article-title":"Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis","volume":"117","author":"Scott","year":"2001","journal-title":"J. Neuroimmunol."},{"issue":"38","key":"10.1016\/j.cca.2025.120275_b0120","doi-asserted-by":"crossref","first-page":"26070","DOI":"10.1074\/jbc.M109.013474","article-title":"PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis","volume":"284","author":"Selvaraj","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cca.2025.120275_b0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jnr.20525","article-title":"Poly(ADP-ribose) polymerase-1 activation in a primate model of multiple sclerosis","volume":"81","author":"Kauppinen","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.cca.2025.120275_b0130","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/jpet.103.063214","article-title":"The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation","volume":"310","author":"Scott","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.cca.2025.120275_b0135","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.bjp.0704934","article-title":"Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats","volume":"137","author":"Chiarugi","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.cca.2025.120275_b0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.molmed.2011.10.002","article-title":"Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?","volume":"18","author":"Cavone","year":"2012","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.cca.2025.120275_b0145","doi-asserted-by":"crossref","DOI":"10.1177\/2055217319894604","article-title":"PARP-1 deregulation in multiple sclerosis","volume":"5","author":"Meira","year":"2019","journal-title":"Multiple Sclerosis J. \u2013 Exp. Transl. Clin."},{"issue":"10","key":"10.1016\/j.cca.2025.120275_b0150","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1358\/dot.2017.53.10.2739609","article-title":"European and Americas committees for treatment and research in multiple sclerosis (ECTRIMS\/ACTRIMS) - 7th joint triennial congress (October 25-28, 2017 - Paris, France)","volume":"53","author":"D\u00edaz","year":"2017","journal-title":"Drugs Today."},{"key":"10.1016\/j.cca.2025.120275_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/969657","article-title":"Is multiple sclerosis an autoimmune disease?","volume":"2012","author":"Wootla","year":"2012","journal-title":"Autoimmune Diseases"},{"issue":"12","key":"10.1016\/j.cca.2025.120275_b0160","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/ni1412","article-title":"Nod-like proteins in immunity, inflammation and disease","volume":"7","author":"Fritz","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2025.120275_b0165","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/sj.cdd.4401890","article-title":"TIR, CARD and PYRIN: three domains for an antimicrobial triad","volume":"13","author":"Werts","year":"2006","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.cca.2025.120275_b0170","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.cca.2025.120275_b0175","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2025.120275_b0180","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbi.2023.10.022","article-title":"Gasdermin D activation in oligodendrocytes and microglia drives inflammatory demyelination in progressive multiple sclerosis","volume":"115","author":"Pollock","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cca.2025.120275_b0185","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neures.2025.02.002","article-title":"Siponimod inhibits microglial inflammasome activation","volume":"213","author":"Komiya","year":"2025","journal-title":"Neurosci. Res."},{"issue":"9","key":"10.1016\/j.cca.2025.120275_b0190","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ni.1775","article-title":"Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE","volume":"10","author":"Farez","year":"2009","journal-title":"Nat. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.cca.2025.120275_b0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-008-1002-8","article-title":"A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis","volume":"255","author":"Weiner","year":"2008","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.cca.2025.120275_b0200","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/157015911796557911","article-title":"Multiple sclerosis: pathogenesis and treatment","volume":"9","author":"Loma","year":"2011","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.cca.2025.120275_b0205","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"The Lancet. Neurology"},{"key":"10.1016\/j.cca.2025.120275_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106785","article-title":"A comparative analysis of the modified Rankin Scale, Karnofsky Performance Status and Kurtzke expanded disability status scale in the perioperative management of patients with brainstem cavernous malformations","volume":"207","author":"Goto","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"6","key":"10.1016\/j.cca.2025.120275_b0215","first-page":"7059","article-title":"Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients","volume":"8","author":"Zhai","year":"2015","journal-title":"Int. J. Clin. Exp. Path."},{"issue":"2","key":"10.1016\/j.cca.2025.120275_b0220","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0006-291X(90)92082-B","article-title":"Characterization of a putative promoter region of the human poly(ADP-ribose) polymerase gene: structural similarity to that of the DNA polymerase beta gene","volume":"167","author":"Ogura","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"27","key":"10.1016\/j.cca.2025.120275_b0225","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1038\/sj.onc.1202778","article-title":"Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor","volume":"18","author":"Soldatenkov","year":"1999","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.cca.2025.120275_b0230","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0300-9084(96)88164-8","article-title":"Regulation of the human poly(ADP-ribosyl) transferase promoter via alternative DNA racket structures","volume":"77","author":"Schweiger","year":"1995","journal-title":"Biochimie"},{"issue":"12","key":"10.1016\/j.cca.2025.120275_b0235","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","article-title":"Progressive multiple sclerosis: from pathophysiology to therapeutic strategies","volume":"18","author":"Faissner","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.cca.2025.120275_b0240","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/brain\/awaa135","article-title":"The NLRP3 inflammasome in progressive multiple sclerosis","volume":"143","author":"Kadowaki","year":"2020","journal-title":"Brain J. Neurol."},{"issue":"7","key":"10.1016\/j.cca.2025.120275_b0245","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41582-020-0366-y","article-title":"NLRP3 inflammasome activity as biomarker for primary progressive multiple sclerosis","volume":"16","author":"Lempri\u00e8re","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.cca.2025.120275_b0250","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12974-020-01944-9","article-title":"Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets","volume":"17","author":"Govindarajan","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cca.2025.120275_b0255","doi-asserted-by":"crossref","unstructured":"Ali A. Abdul-Sater, Dana J. Philpott, Inflammasomes, Editor(s): Michael J.H. Ratcliffe, Encyclopedia of Immunobiology, Academic Press, 2016, Pages 447-453, ISBN 9780080921525, https:\/\/doi.org\/10.1016\/B978-0-12-374279-7.10020-7.","DOI":"10.1016\/B978-0-12-374279-7.10020-7"},{"issue":"6","key":"10.1016\/j.cca.2025.120275_b0260","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.4049\/jimmunol.1001512","article-title":"Cutting edge: proteolytic inactivation of poly(ADP-ribose) polymerase 1 by the Nlrp3 and Nlrc4 inflammasomes","volume":"185","author":"Malireddi","year":"2010","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cca.2025.120275_b0265","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molcel.2012.02.016","article-title":"Inflammasome-activated caspase 7 cleaves PARP1 to enhance the expression of a subset of NF-\u03baB target genes","volume":"46","author":"Erener","year":"2012","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.cca.2025.120275_b0270","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1007\/s12035-017-0793-y","article-title":"Cell death pathways: a novel therapeutic approach for neuroscientists","volume":"55","author":"Morris","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.cca.2025.120275_b0275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00018-022-04138-z","article-title":"PARP-1 regulates inflammasome activity by poly-ADP-ribosylation of NLRP3 and interaction with TXNIP in primary macrophages","volume":"79","author":"Chiu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.cca.2025.120275_b0280","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","article-title":"Secondary progressive multiple sclerosis: new insights","volume":"97","author":"Cree","year":"2021","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.cca.2025.120275_b0285","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/iub.2048","article-title":"Parp inhibition by olaparib alleviates chronic asthma-associated remodeling features via modulating inflammasome signaling in mice","volume":"71","author":"Sethi","year":"2019","journal-title":"IUBMB Life"},{"issue":"10","key":"10.1016\/j.cca.2025.120275_b0290","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3390\/cells9102286","article-title":"Modulation of inflammasome and pyroptosis by olaparib, a PARP-1 inhibitor, in the R6\/2 mouse model of Huntington's disease","volume":"9","author":"Paldino","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.cca.2025.120275_b0295","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jcla.20379","article-title":"Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease","volume":"24","author":"Liu","year":"2010","journal-title":"J. Clin. Lab. Anal."},{"issue":"3","key":"10.1016\/j.cca.2025.120275_b0300","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000381985","article-title":"Variants of base excision repair genes MUTYH PARP1 and XRCC1 in Alzheimer's disease risk","volume":"71","author":"Kwiatkowski","year":"2015","journal-title":"Neuropsychobiology"},{"issue":"7","key":"10.1016\/j.cca.2025.120275_b0305","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/mp.2013.24","article-title":"Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment","volume":"18","author":"Nho","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.cca.2025.120275_b0310","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.12659\/MSM.898091","article-title":"Single-nucleotide polymorphisms of genes involved in repair of oxidative DNA damage and the risk of recurrent depressive disorder","volume":"22","author":"Czarny","year":"2016","journal-title":"Medical Sci. Monitor: Int. Medical J. Exp. Clin. Res."},{"issue":"2","key":"10.1016\/j.cca.2025.120275_b0315","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s11033-021-06169-4","article-title":"PARP1 rs1136410 C\/C genotype associated with an increased risk of esophageal cancer in smokers","volume":"48","author":"Zhou","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.cca.2025.120275_b0320","doi-asserted-by":"crossref","DOI":"10.1177\/0300060521992956","article-title":"PARP1rs1136410 Val762Ala contributes to an increased risk of overall cancer in the East Asian population: a meta-analysis","volume":"49","author":"Xin","year":"2021","journal-title":"J. Int. Med. Res."},{"issue":"24","key":"10.1016\/j.cca.2025.120275_b0325","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1111\/jcmm.16027","article-title":"Contributions of PARP-1 rs1136410 C>T polymorphism to the development of cancer","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"18","key":"10.1016\/j.cca.2025.120275_b0330","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.7150\/jca.34222","article-title":"PARP1gene polymorphisms and neuroblastoma susceptibility in Chinese children","volume":"10","author":"Cheng","year":"2019","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2025.120275_b0335","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/gepi.20663","article-title":"Association between PARP-1 V762A polymorphism and cancer susceptibility: a meta-analysis","volume":"36","author":"Yu","year":"2012","journal-title":"Genet. Epidemiol."},{"issue":"22","key":"10.1016\/j.cca.2025.120275_b0340","doi-asserted-by":"crossref","first-page":"16220","DOI":"10.18632\/oncotarget.23804","article-title":"Polymorphisms in BER genes and risk of breast cancer: evidences from 69 studies with 33760 cases and 33252 controls","volume":"9","author":"Qiao","year":"2018","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.cca.2025.120275_b0345","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.parkreldis.2011.06.022","article-title":"Association analysis of PARP1 polymorphisms with Parkinson's disease","volume":"17","author":"Brighina","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"issue":"3","key":"10.1016\/j.cca.2025.120275_b0350","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/1567202618666210916122553","article-title":"Poly(adenosine diphosphate ribose) polymerase-1 single nucleotide polymorphism in the 3'-untranslated region for ischemic stroke risk reduction","volume":"18","author":"Gu","year":"2021","journal-title":"Curr. Neurovasc. Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120275_b0355","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7150\/jca.49925","article-title":"The association of polymorphisms in base excision repair genes with ovarian cancer susceptibility in Chinese Women: a two-center case-control study","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.cca.2025.120275_b0360","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejogrb.2020.10.021","article-title":"A functional polymorphism in the poly(ADP-ribose) polymerase-1 gene is associated with platinum-based chemotherapeutic response and prognosis in epithelial ovarian cancer patients","volume":"255","author":"Zhao","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.cca.2025.120275_b0365","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8289293","article-title":"The Effect ofPoly(ADP-ribose) Polymerase-1Gene 3'untranslated region polymorphism in colorectal cancer risk among saudi cohort","volume":"2016","author":"Alhadheq","year":"2016","journal-title":"Dis. Markers"},{"issue":"3","key":"10.1016\/j.cca.2025.120275_b0370","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/carcin\/bgr300","article-title":"The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes","volume":"33","author":"Teo","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cca.2025.120275_b0375","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/1471-2407-14-603","article-title":"PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models","volume":"14","author":"Guillot","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cca.2025.120275_b0380","doi-asserted-by":"crossref","unstructured":"Abdul Sater, Ali & Philpott, Dana. (2016). Inflammasomes. Encyclopedia of Immunobiology. 10.1016\/B978-0-12-374279-7.10020-7.","DOI":"10.1016\/B978-0-12-374279-7.10020-7"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125001548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125001548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:29:57Z","timestamp":1754407797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125001548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":76,"alternative-id":["S0009898125001548"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120275","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PARP-1 gene promoter region may be associated with progression in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120275"}}